Despite these challenges, we can do more to disrupt the illicit trade of these chemicals.
In recent years, countries have imposed new restrictions on the chemicals used to make fentanyl. But so far, the measures have mostly focused on how the chemicals are being used, rather than controlling their transit at every point. Under American pressure, China has tightened the screws on illicit fentanyl manufacturing within its borders, placing all forms of fentanyl on its controlled substances list in 2019, and subjecting these drugs to stricter oversight.
But the Chinese government has paid far less scrutiny to the booming trade in precursor chemicals. The United States needs to again demand that China zero in on these chemicals as part of its broader crackdown on fentanyl.
At the same time, the United States working with like-minded countries can institute more stringent global regulations based on international drug control agreements. Such regulations must also target new “pre-precursor” chemicals (more basic formulations of existing chemicals) that cartels use to evade scrutiny.
This can include requiring chemical manufacturers and shipping companies doing any business with the United States and its partners to more aggressively track these chemicals from the moment they arrive on the soil of a partner nation to the very end of their supply chains.
This would help better separate legitimate sales from illegitimate ones, and would allow easier identification and reporting of suspicious orders. We also need to make wider use of technologies that can help customs agents test chemicals in the field.
Giving regulatory agencies the power to crack down on manufacturing tools like equipment used to press fentanyl pills is the other crucial part of the equation. Much of the illegal trade is coming from labs with complex rotary presses that can produce tens of thousands of tablets an hour. In China and other countries, these machines are made by specialized companies — so it’s possible to target them with stricter controls.
Federal law requires firms that buy or sell pill presses in the United States to report these transactions to the Drug Enforcement Administration. As for foreign commerce outside the United States, greater international cooperation, the sale of this equipment can be more tightly regulated to ensure it goes only to legitimate outfits.
Such regulation includes more rigorous background checks of buyers’ credentials, advanced tracking of machines from the point of sale to their destination, regular audits of these rules and more stringent penalties for noncompliance. Any firm that wants to make legitimate sales in the United States and its partners would have to adhere to these conditions on all of their transactions, even those outside U.S. jurisdiction.